SEC Form 4 · accession 0001127602-16-063962
CONMED Corp · CNMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jerome J. Lande
Director
Period of report
Sep 30, 2016
Accepted (ET)
Oct 4, 2016 · 2:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000816956
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 7,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options To Purchase Common StockF2 | $41.06 | Sep 30, 2016 | D | 5,396 | D | Jun 1, 2017 | Jun 1, 2026 | Common Stock | 5,396 | 0 | D |
| Rsus (restricted Stock Units)F3 | $0.00 | Sep 30, 2016 | D | 2,739 | D | Jun 1, 2017 | Jun 1, 2026 | Common Stock | 2,739 | 0 | D |
Explanation of responses
- F1At Mr. Lande's request, the Board cancelled his 2016 RSUs and Stock Options. Mr. Lande received no value for the cancellation of these RSUs and Stock Options.
- F2The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and otherwise would have vested 100% after a one year period.
- F3Each restricted stock unit ("RSU") represented a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and were subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs otherwise generally vesting 100% after a one year period.